Donald Trump’s “most favored nation” strategy for the U.S. could force up prices in Europe — and make medicines scarcer.

DoC begins stakeholder consultations with Pharmexcil & industry on trade negotiations with Peru & Chile: Shardul Nautiyal, Mumbai Wednesday, August 20, 2025, 08:00 Hrs [IST] The U ...

Enterprise software maker EliseAI has raised $250 million in a Series E funding round to expand its automation tools for the healthcare and housing industries, the company told Reuters.

After an unusual first quarter in which seven of the biopharma industry’s | Several U.S. pharma companies that had posted ...

This partnership offers a preview of the future: smarter containers that integrate renewable energy, digital visibility, and lightweight design into one solution.

As China rises and other global cities aggressively court biotech talent, Massachusetts faces a "contracting moment" that has ...

The EQUIP-A-Pharma program will combine Battelle’s synthesis platform and Aprecia’s 3D printing technology to produce APIs and finished drugs at the same site, aiming to strengthen US pharma supply ...

The technology once embraced by President Donald Trump for speeding the development of COVID-19 vaccines is now under scrutiny. Health Secretary Robert F. Kennedy Jr. recently took sweeping action ...

What Happened: Hudson's decision to sell 7,457 shares of Supernus Pharmaceuticals was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Monday. The total value of the ...

We note that last year, analysts projected Elevance would earn about $39 a share in 2025. Today, those estimates are around ...

Conflicts of interest on federal government vaccine panels have declined to “historically low levels” in recent years ...

With Trump's backing, the pharma industry is leaning into the idea of more "direct-to-consumer" sales. But experts say the ...